Neonatal Hypoglycemia
32
6
6
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
2 terminated out of 32 trials
86.7%
+0.2% vs benchmark
16%
5 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (32)
COntinuous Glucose Monitoring in nEwborns of Mothers With Insulin-Treated Gestational Diabetes Mellitus
Pasteurised Donor Human Milk Supplementation for Term Babies
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
Neurodevelopment of Hypoglycemic Neonates
Accuracy of Interstitial Continuous Glucose Sensors in Neonates
Continuous Glucose Monitoring in At-Risk Newborns
Frequency of Glucose Monitoring in Labor
The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment
Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Immediate Skin-To-Skin Contact and Early Breastfeeding During Caesarean Section
Continuous Glucose Monitoring in Infants
Intrapartum Glycemic Control in GDMA2
Glucose Disturbances in Premature Infants and Quality of Life
Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan
Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant